According to the FDA, Upneeq is safe and effective for the treatment of acquired eyelid ptosis in healthy adults. To gain approval, Upneeq showed effectiveness in four clinical trials that followed 568 patients with acquired blepharoptosis.
In the clinical trials, oxymetazoline 0.1% was administered once daily for 14-84 days. The most common side effects of Upneeq (occurring in 1–5% of patients) were:
- Eye inflammation, redness, and irritation
- Dry eye
- Blurred vision
- Eye pain around the time of use
- Headache
While most side effects are mild, Upneeq may not be right for everyone, especially those with underlying medical conditions.
- Because Upneeq may impact blood pressure, people with cardiovascular disease, orthostatic hypotension, and/or uncontrolled hypertension or hypotension should monitor their condition and seek medical care if it worsens while they’re using Upneeq.
- Patients with Sjögren’s syndrome, an immune system disorder, should also contact their doctor if symptoms worsen.
- If you have untreated glaucoma, Upneeq could make it worse. Seek medical attention right away if you feel increased pressure in your eye after applying the drops.
You can get a prescription online without being seen by a doctor, and many types of physicians offer it, which concerns some eye specialists. “Any patient who’s being prescribed Upneeq should be evaluated by an ophthalmologist,” advises Dr. Khan. “Acquired blepharoptosis has a broad differential diagnosis, which can include certain underlying neurological conditions of an acute nature—such as Horner’s syndrome, stroke, and mixed cranial nerve palsy—that should be ruled out prior to masking a potentially life-threatening issue with an eye drop.”
Another consideration: daily use may not be healthy long-term. “Our eye’s blood vessels have a critical role in delivering oxygen and nutrients for proper functioning of the eye’s tissues and tear film to optimize our vision,” Dr. Khan explains.
Regular use of Upneeq may lead to rebound redness, when the blood vessels stop reverting back to their original size once the drug wears off. A rebound effect wasn’t seen in Upneeq studies, but it’s a possibility, since the active ingredient in Upneeq may constrict blood vessels.
Another possibility is rebound congestion. “It’s a probable adverse outcome, as it is for Afrin nasal spray, which is routinely recommended for only 2-3 consecutive days because it can cause worsening of congestion after that time frame,” says Dr. Khan.
Due to these concerns, some providers don’t consider Upneeq a good long-term option and only prescribe it for a few weeks. Discuss with your doctor how long it’s appropriate for you to use Upneeq.